US 7687459
Arylalkoxyl hepatitis C virus protease inhibitors
granted A61KA61K38/21A61K38/212
Quick answer
US patent 7687459 (Arylalkoxyl hepatitis C virus protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/21, A61K38/212, A61P, A61P31/12